Where To Give Allergy Shots: Site, Route, and Injection Technique
Allergy shots are given in the upper outer arm — posterolateral aspect of the deltoid, subcutaneously (SC, not IM) — alternating arms each visit, with a 26G or 27G ½-inch needle on a 1-mL tuberculin syringe (Cox 2011 PP3, Summary Statements 13-14; ACAAI guidance). Administration must occur under physician supervision since UnitedHealthcare ended home SCIT coverage January 1, 2023.
5 peer-reviewed sources
Give allergy shots subcutaneously in the posterolateral upper arm, alternating sides each visit, 26-27G ½-inch needle on 1-mL tuberculin syringe. Never IM. Mandatory 30-minute supervised observation after each injection.
The essentials
Allergy shots are given in the upper outer arm — the posterolateral aspect of the deltoid region — subcutaneously, alternating arms each visit, with a 26G or 27G ½-inch needle on a 1-mL tuberculin syringe (Cox L et al., J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, DOI 10.1016/j.jaci.2010.09.034, Summary Statements 13-14; ACAAI administration guidance). The verb "give" tilts this page toward clinical learners — nursing students, medical assistants, allergist trainees, or patients self-administering at home — alongside patients verifying correct technique. The answer is the same for both audiences.
Three clinical decisions anchor every allergy shot administration:
Site: Upper outer arm, posterolateral to the deltoid, avoiding the medial arm (brachial artery and nerve proximity), the deltoid tuberosity, and the bicipital groove. The posterolateral deltoid provides adequate subcutaneous fat depth with minimal neurovascular risk.
Route: Subcutaneous (SC), never intramuscular (IM) and never intradermal. IM delivery increases systemic allergen absorption rate and reaction risk — muscle is more vascular than subcutaneous fat, and rapid allergen delivery into the bloodstream can trigger IgE-mediated mast cell degranulation before the regulatory immune response is established. Intradermal route is reserved for diagnostic allergy skin testing (CPT 95024), not immunotherapy.
Laterality: Alternate arms each visit (Summary Statement 14). This limits cumulative local-reaction load on a single deltoid — important because 78.3% of patients develop at least one local reaction across their SCIT course (LOCAL study, Calabria CW, Coop CA, Tankersley MS, J Allergy Clin Immunol 2009;124[4]:739-744, PMID 19767075). Per-injection local-reaction rate is 16.3%; large local reactions occur in 0.4% of injections.
Curex's at-home SCIT kit ($129/month, all-inclusive) uses exactly this technique — posterolateral deltoid, subcutaneous, alternating arms — so patients can self-administer weekly at home. A board-certified allergist reviews intake, the personalized serum is sterile-compounded to USP <797>, and the first injection plus every dose change are supervised live over Zoom by the prescribing physician.
Pre-injection screening is the safety backbone of SCIT administration: current symptom status, asthma control, fever, any new medications (beta-blockers, ACE inhibitors), pregnancy status, peak flow in asthmatics. Epstein TG et al. (Ann Allergy Asthma Immunol 2013, PMID 23535092, Year 3 surveillance) found 86% of US clinics always screen for worsening asthma before every injection. Curex patients complete an equivalent pre-injection screen each week. Aspiration before injection is no longer universally required (Cox 2011 PP3, Summary Statement 61). Volume ranges from 0.05–0.10 mL initial build-up to 0.5 mL maintenance. Avoid vigorous exercise approximately 2 hours before and after — exercise increases systemic allergen absorption.
After the injection: a 30-minute self-observation period (Summary Statement 32 documents the timing of most systemic reactions). Post-injection, document the arm used, dose administered, lot number, and any reactions. UnitedHealthcare ended home/self-administered SCIT coverage January 1, 2023 — patients seeking at-home SCIT should ask about Curex's direct-pay model, which bypasses traditional insurer restrictions at $129/month.
For patients whose answer to "where to give" is "nowhere — I prefer not to inject at all": FDA-approved sublingual SLIT tablets (Grastek, Oralair, Ragwitek, Odactra) are a needle-free oral alternative for eligible single-sensitization profiles.
How allergy shots retrain your immune system
The posterolateral deltoid is specified because subcutaneous fat in this zone provides optimal allergen depot conditions: slow, controlled release into a relatively avascular tissue allows antigen-presenting cells to process the allergen without triggering immediate IgE-mediated mast cell degranulation. The fat-to-muscle boundary is critical — going too deep into the deltoid muscle delivers allergen into high-vascular tissue, accelerating systemic absorption and elevating systemic reaction risk. The 26-27G needle is the finest practical gauge for the prescribed 0.05-0.5 mL volumes and ensures the tip remains in the subcutaneous fat layer rather than penetrating to muscle.
Perform pre-injection screening
Screen for current symptoms, asthma control, new medications (beta-blockers, ACE inhibitors), peak flow in asthmatics, pregnancy status, fever, any reactions since the last injection. Document and notify the supervising allergist if any flag is present.
Prepare the correct dose
Verify the vial label against the prescribed dose schedule. Draw the ordered volume (0.05-0.5 mL) into a 1-mL tuberculin syringe with a 26G or 27G ½-inch needle. Confirm the correct allergen vial color-band/label before drawing.
Inject into posterolateral deltoid, SC, alternate arms
Pinch the subcutaneous fat at the posterolateral deltoid, insert the needle at 90° (45° for lean patients), deliver slowly. Aspiration no longer universally required (Cox 2011 PP3, Summary Statement 61). Document which arm received the injection.
Observe 30 minutes and grade any reactions
Observe for 30 minutes after injection — at home, remain seated and accessible. Any systemic symptoms — generalized hives, throat tightness, difficulty breathing, lightheadedness — require using your prescribed epinephrine auto-injector immediately and calling 911. On a Zoom-supervised dose (first injection or any dose change), your allergist directs treatment live. Grade any reactions using the WAO 5-grade system (Cox L, Larenas-Linnemann D, JACI 2010) and report to your care team before the next scheduled dose.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youFrequently asked questions
Can a medical assistant (MA) give allergy shots?
Yes — in most US states, a medical assistant (MA) or registered nurse (RN) can administer allergy shots under a board-certified allergist's protocol and supervision. The allergist must have evaluated the patient, formulated the allergen extract, and established the dose schedule. The administering MA or RN must be trained in anaphylaxis recognition and management, and the facility must have epinephrine and resuscitation equipment on-site. State medical practice acts vary — some states restrict injection administration to RNs or higher. The allergist must be available (not necessarily in the room) to manage adverse reactions. Pre-injection screening by the MA before each dose is standard practice and is a key safety checkpoint.
What should the pre-injection screening checklist include?
Per Cox L et al. (J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55) and the Epstein 2013 surveillance findings (PMID 23535092), the pre-injection screening should check: (1) current symptoms — worsening rhinitis, asthma, urticaria; (2) asthma control — wheeze, shortness of breath, recent exacerbation; (3) peak flow measurement in asthmatic patients; (4) any new medications since last visit — particularly beta-blockers (impair epinephrine response to anaphylaxis) and ACE inhibitors; (5) pregnancy status; (6) fever; (7) any reactions since the last injection. If asthma is uncontrolled or the patient reports significant worsening symptoms, the dose should be held and the allergist consulted before proceeding. The Epstein 2013 Year 3 surveillance found 86% of US clinics always screen for worsening asthma before every injection.
How do I tell if I injected SC or IM accidentally?
An intramuscular injection typically causes sharper pain during the injection than a subcutaneous one, because skeletal muscle has a denser pain receptor network than subcutaneous fat. IM delivery into the deltoid can also produce a distinct resistance sensation during plunger depression if the needle tip is within muscle rather than fat. After the injection, IM sites often cause next-day muscle ache (similar to a typical vaccine), whereas SC sites typically produce a local superficial wheal or no palpable induration at all. If a patient reports unusually sharp injection pain or develops systemic symptoms unusually rapidly after the injection, document the likely IM delivery and monitor carefully through the full 30-minute observation window. Notify the prescribing allergist and consider dose adjustment before the next visit.
What do I do if there is a large local reaction during the 30-minute observation?
A large local reaction (LLR) — swelling ≥25 mm or larger than the patient's palm at the injection site — during the observation period is a significant local immune response but is not typically a systemic emergency. Per the LOCAL study (Calabria CW, Tankersley MS, JACI 2009, PMID 19767075), LLRs occur in about 0.4% of injections. Management: apply ice to the site, administer an oral antihistamine if available, monitor the patient through the full 30-minute window, and document the reaction size and timing. Notify the supervising allergist, who may decide to hold the current dose or step back before the next escalation. LLRs do not reliably predict systemic reactions — in the LOCAL study, positive predictive value of a local reaction for a subsequent local reaction was 27.2%. If the patient develops any systemic symptoms — hives beyond the injection site, throat tightness, difficulty breathing — escalate immediately to anaphylaxis protocol.
Why is home SCIT administration no longer allowed?
Traditional in-clinic SCIT is no longer covered by some major US insurers for home self-administration: UnitedHealthcare ended home/self-administered SCIT coverage effective January 1, 2023. The historical concern is real — approximately 70% of severe systemic reactions begin within 30 minutes of injection (Cox L et al., J Allergy Clin Immunol 2011;127[1 Suppl]:S1-S55, Summary Statement 32), so immediate access to an epinephrine auto-injector and emergency care matters. Curex's scit-v1 model addresses exactly this concern through a structured safeguard stack for eligible maintenance patients: before the first dose, your allergist prescribes an epinephrine auto-injector that you obtain from a pharmacy and confirm is on hand (Curex does not supply it); your first injection and every dose change are supervised live over Zoom by the prescribing physician; your personalized serum is sterile-compounded to USP <797>; and dose escalation proceeds gradually under allergist oversight. AAAAI/ACAAI surveillance (Epstein TG et al., PMID 23535092) credits post-injection observation and immediate epinephrine availability with enabling rapid intervention — both pillars are preserved in the at-home model.
Does the patient need to be seated or lying down for allergy shots?
Most US allergist offices administer allergy shots with the patient seated in a chair or on a treatment table. A supine (lying-down) position may be preferable for patients with a history of vasovagal syncope (fainting) in response to injections, as lying down reduces the risk of injury if syncope occurs. Some patients with severe needle phobia benefit from a reclining position. The injection technique itself is the same regardless of patient position. Cox 2011 PP3 does not specify a mandatory position but does require that the patient remain in the supervised clinical setting for the 30-minute observation window. After the shot, patients typically move to an observation waiting area — they should not drive during the observation period.
Can allergy shots be given at the same visit as other vaccines or injections?
CMS NCCI Policy Manual notes that allergy testing (CPT 95004) and allergy immunotherapy (CPT 95117) are generally not performed on the same day in standard medical practice. The interaction between allergy shots and other same-day injectable medications (flu vaccines, other immunizations) should be discussed with the prescribing allergist. Some allergists prefer to separate allergy shots and other vaccines by at least 1-2 weeks to avoid confounding any local or systemic reactions. There is no absolute contraindication in Cox 2011 PP3 against same-day vaccine administration, but individual allergist protocols vary. Medications like epinephrine (rescue) are used reactively, not co-administered. Beta-blockers and ACE inhibitors are contraindications or cautions that affect SCIT safety and must be flagged at every pre-injection screen.
Related Articles
Where Should Allergy Shots Be Given? | Curex Guide
Per Cox 2011 PP3: subcutaneous, upper outer arm, alternating arms, 26-27G needle. Correct technique applies to clinic shots and Curex at-home SCIT.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreWhere To Give Allergy Shots In Arm | Curex Guide
Upper outer arm (posterolateral deltoid), SC, 26-27G, alternating arms. 78.3% get a local reaction. At-home SCIT: Curex $129/mo.
Read moreAllergy Shot Schedule: Full Timeline Guide | Curex
Allergy shot schedule: weekly build-up 24–28 wks, maintenance every 2–4 wks × 3–5 yrs (Cox 2011). Cluster, rush variants and at-home option explained.
Read moreAllergy Shots for Dog Allergies | Curex Human SCIT Guide
Allergy shots for dog allergies treat HUMANS — not dogs. Dog SCIT evidence is 'poor and conflicting' (Smith 2016). 16.5% of dog-sensitized adults can skip shots entirely.
Read moreAre Allergy Shots Bad For You? | Curex Allergy Shot Guide
No — allergy shots are not bad for you: 1 fatality across 23.3 million injections (2008-2012), 0.1% systemic-reaction rate per visit. Full safety breakdown inside.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.